中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2001年
2期
57-60
,共4页
陶永辉%金坚%张荣军%何扬%张满达%阮长耿
陶永輝%金堅%張榮軍%何颺%張滿達%阮長耿
도영휘%금견%장영군%하양%장만체%원장경
红细胞生成素%血栓调节素%尿%亲和层析%分离
紅細胞生成素%血栓調節素%尿%親和層析%分離
홍세포생성소%혈전조절소%뇨%친화층석%분리
目的从人尿中分离纯化红细胞生成素(EPO)和血栓调节素(TM)。方法用超滤浓缩、离子交换层析及亲和层析等方法从新鲜人尿中分别纯化EPO和TM。结果从2 000 kg新鲜人尿中分别纯化得到了4.47 mg EPO和9.92 mg TM,得率分别为31.9%和25.0%,分子量分别为(38.6±1.0)kD和(60±1.4)kD;等电点分别为3.60±0.02和3.70±0.02;TM富含Glu、Ala和Gly,毛细管区带电泳分析高度均一,有关生化参数与文献报道基本一致。结论该工艺可获得纯度较高的EPO和TM。
目的從人尿中分離純化紅細胞生成素(EPO)和血栓調節素(TM)。方法用超濾濃縮、離子交換層析及親和層析等方法從新鮮人尿中分彆純化EPO和TM。結果從2 000 kg新鮮人尿中分彆純化得到瞭4.47 mg EPO和9.92 mg TM,得率分彆為31.9%和25.0%,分子量分彆為(38.6±1.0)kD和(60±1.4)kD;等電點分彆為3.60±0.02和3.70±0.02;TM富含Glu、Ala和Gly,毛細管區帶電泳分析高度均一,有關生化參數與文獻報道基本一緻。結論該工藝可穫得純度較高的EPO和TM。
목적종인뇨중분리순화홍세포생성소(EPO)화혈전조절소(TM)。방법용초려농축、리자교환층석급친화층석등방법종신선인뇨중분별순화EPO화TM。결과종2 000 kg신선인뇨중분별순화득도료4.47 mg EPO화9.92 mg TM,득솔분별위31.9%화25.0%,분자량분별위(38.6±1.0)kD화(60±1.4)kD;등전점분별위3.60±0.02화3.70±0.02;TM부함Glu、Ala화Gly,모세관구대전영분석고도균일,유관생화삼수여문헌보도기본일치。결론해공예가획득순도교고적EPO화TM。
Purpose The aim is to isolate and purify the erythropoietin(EPO)and thrombomodulin(TM) from human urine.Methods Purifying and isolating human urine with means of filtration and concentration,ion-exchange chromatography, affinity chromatography and so on.Results 4.47 mg EPO and 9.92 mg TM were obtained from 2 000 kg human urine.Their molecular weights were(38.6±1.0)kD and (60±1.4)kD erespectively, the isoelectric point, 3.60±0.02 and 3.70±0.02, yield, 31.9% and 25.0%.The purified EPO and TM was shown to be highly homogeneous by capillary zone-electrophoresis(CZE),abundant Glu,Ala and Gly include on TM. Conclusion The high purity EPO and TM was obtained.